BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24009426)

  • 1. MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia.
    Dou L; Li J; Zheng D; Li Y; Gao X; Xu C; Gao L; Wang L; Yu L
    Onco Targets Ther; 2013; 6():1153-60. PubMed ID: 24009426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.
    Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L
    Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-27a downregulates 14-3-3θ, RUNX1, AF4, and MLL-AF4, crucial drivers of blast transformation in t(4;11) leukemia cells.
    Fioretti T; Zanobio M; Raia M; Errichiello S; Izzo B; Cattaneo F; Ammendola R; Cevenini A; Esposito G
    Cell Biochem Funct; 2022 Oct; 40(7):706-717. PubMed ID: 35981137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene.
    Dou L; Li J; Zheng D; Li Y; Gao X; Xu C; Gao L; Wang L; Yu L
    Mol Biol Rep; 2013 Dec; 40(12):6811-9. PubMed ID: 24057258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
    Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ
    J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
    Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K
    Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
    Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
    Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.
    Bertrand FE; Vogtenhuber C; Shah N; LeBien TW
    Blood; 2001 Dec; 98(12):3398-405. PubMed ID: 11719380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells.
    Thomas M; Gessner A; Vornlocher HP; Hadwiger P; Greil J; Heidenreich O
    Blood; 2005 Nov; 106(10):3559-66. PubMed ID: 16046533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.
    Lin S; Luo RT; Ptasinska A; Kerry J; Assi SA; Wunderlich M; Imamura T; Kaberlein JJ; Rayes A; Althoff MJ; Anastasi J; O'Brien MM; Meetei AR; Milne TA; Bonifer C; Mulloy JC; Thirman MJ
    Cancer Cell; 2016 Nov; 30(5):737-749. PubMed ID: 27846391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
    Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
    Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.
    Bursen A; Schwabe K; Rüster B; Henschler R; Ruthardt M; Dingermann T; Marschalek R
    Blood; 2010 Apr; 115(17):3570-9. PubMed ID: 20194896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells.
    Kotani A; Ha D; Schotte D; den Boer ML; Armstrong SA; Lodish HF
    Cell Cycle; 2010 Mar; 9(6):1037-42. PubMed ID: 20237425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeted regulation of mll-af4 fusion gene by miR-142-3p].
    Dou LP; Li YH; Xu CW; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1595-9. PubMed ID: 21176377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
    Uckun FM; Herman-Hatten K; Crotty ML; Sensel MG; Sather HN; Tuel-Ahlgren L; Sarquis MB; Bostrom B; Nachman JB; Steinherz PG; Gaynon PS; Heerema N
    Blood; 1998 Aug; 92(3):810-21. PubMed ID: 9680349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AF4 encodes a ubiquitous protein that in both native and MLL-AF4 fusion types localizes to subnuclear compartments.
    Li Q; Frestedt JL; Kersey JH
    Blood; 1998 Nov; 92(10):3841-7. PubMed ID: 9808577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34
    Prieto C; Marschalek R; Kühn A; Bursen A; Bueno C; Menéndez P
    Oncotarget; 2017 Oct; 8(47):81936-81941. PubMed ID: 29137234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins.
    Ng MH; Ng RK; Kong CT; Jin DY; Chan LC
    Exp Hematol; 2010 Jun; 38(6):481-8. PubMed ID: 20362031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221.
    Kotani A; Ha D; Hsieh J; Rao PK; Schotte D; den Boer ML; Armstrong SA; Lodish HF
    Blood; 2009 Nov; 114(19):4169-78. PubMed ID: 19749093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.